GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cardiovascular Systems Inc (FRA:R7Y1) » Definitions » Price-to-Owner-Earnings

Cardiovascular Systems (FRA:R7Y1) Price-to-Owner-Earnings : (As of May. 24, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Cardiovascular Systems Price-to-Owner-Earnings?

As of today (2024-05-24), Cardiovascular Systems's share price is €18.00. Cardiovascular Systems does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Cardiovascular Systems's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Cardiovascular Systems was 2226.15. The lowest was 0.00. And the median was 1882.31.


FRA:R7Y1's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 33.29
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-24), Cardiovascular Systems's share price is €18.00. Cardiovascular Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022 was €-0.93. Therefore, Cardiovascular Systems's PE Ratio (TTM) for today is At Loss.

As of today (2024-05-24), Cardiovascular Systems's share price is €18.00. Cardiovascular Systems's EPS without NRI for the trailing twelve months (TTM) ended in was €-0.93. Therefore, Cardiovascular Systems's PE Ratio without NRI for today is At Loss.

During the past 13 years, Cardiovascular Systems's highest PE Ratio without NRI was 1895.00. The lowest was 0.00. And the median was 795.28.


Cardiovascular Systems Price-to-Owner-Earnings Historical Data

The historical data trend for Cardiovascular Systems's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiovascular Systems Price-to-Owner-Earnings Chart

Cardiovascular Systems Annual Data
Trend Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cardiovascular Systems Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cardiovascular Systems's Price-to-Owner-Earnings

For the Medical Devices subindustry, Cardiovascular Systems's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardiovascular Systems's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cardiovascular Systems's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cardiovascular Systems's Price-to-Owner-Earnings falls into.



Cardiovascular Systems Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cardiovascular Systems's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=18.00/-1.08
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cardiovascular Systems  (FRA:R7Y1) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Cardiovascular Systems Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Cardiovascular Systems's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardiovascular Systems (FRA:R7Y1) Business Description

Traded in Other Exchanges
N/A
Address
1225 Old Highway 8 Northwest, Saint Paul, MN, USA, 55112-6416
Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generate the vast majority of its revenue in the United States.

Cardiovascular Systems (FRA:R7Y1) Headlines

No Headlines